Literature DB >> 16890179

Alteration of the influences of HLA classes I and II alleles on the perinatal hepatitis B virus infection after immunoprophylaxis in Korean children.

Jong-Hyun Kim1, Chul-Woo Pyo, Dae Kyun Koh, Jae Kyun Hur, Jin Han Kang, Tai-Gyu Kim.   

Abstract

Some HLA alleles are known to be associated with hepatitis B virus (HBV) persistence. In order to find out the relationship between HLA and perinatal HBV infection after prophylaxis, we typed HLA classes I and II in 38 HBeAg-positive mothers, their children (19 succeeded and 19 failed in prophylaxis) and 198 HBsAg-negative healthy controls. HLA-B35 (RR=2.8, p<0.03), Cw*07 (RR=2.7, p<0.02), DRB1*07 (RR=3.6, p<0.006), DQA1*02 (RR=3.6, p<0.02) and DQB1*02 (RR=2.4, p<0.05) alleles were higher and DRB1*13 (RR=0.3, p<0.03) and DPB1*0401 (RR=0.1, p<0.01) alleles were lower frequencies in HBeAg-positive mothers than in the control. In failed children to the perinatal HBV prophylaxis, HLA-Cw*0303 allele was significantly higher (p<0.05) and DPB1*0202 allele was lower (p<0.03) than in succeeded children. These results suggest the influences of certain HLA alleles on naturally acquired chronic HBV infection may be changed by perinatal HBV prophylaxis.

Entities:  

Year:  2006        PMID: 16890179     DOI: 10.1016/j.hepres.2006.03.004

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  3 in total

1.  Association of Chlamydia pneumoniae infection with HLA-B*35 in patients with coronary artery disease.

Authors:  Anil Palikhe; Marja-Liisa Lokki; Pekka Saikku; Maija Leinonen; Mika Paldanius; Mikko Seppänen; Ville Valtonen; Markku S Nieminen; Juha Sinisalo
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

Review 2.  HLA and infectious diseases.

Authors:  Jenefer M Blackwell; Sarra E Jamieson; David Burgner
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

3.  The association of HLA-DRB1 alleles and drug use with HIV infection in a Chinese Han Cohort.

Authors:  Bo Diao; Juan Du; Ying Liu; Fan Luo; Wei Hou
Journal:  Braz J Infect Dis       Date:  2013-09-09       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.